Alberta Health Services - University of Calgary

Calgary, Alberta T2N 1N4

1 studies enrolling now · 2 studies all time

What they study most

Complete Response, Epithelial Ovarian Cancer, FIGO Stage III-IV, Fallopian Tube Cancer, Newly Diagnosed, Partial Response, Primary Peritoneal, Transthyretin Amyloidosis (ATTR) With Cardiomyopathy

Studies at this site

• MAGNITUDE: A Phase 3 Study of NTLA-2001 in Participants With Transthyretin Amyloidosis With Cardiomyopathy (ATTR-CM) — Recruiting now
• A Study in Ovarian Cancer Patients Evaluating Rucaparib and Nivolumab as Maintenance Treatment Following Response to Front-Line Platinum-Based Chemotherapy — Running, not enrolling